
Mark Walters, MD
Professor
Pediatrics
Mark Walters, MD develops and expands curative therapies for hemoglobin disorders and non-malignant hematopoietic disorders. He pursues genomic editing of the sickle mutation in hematopoietic stem cells using the CRISPR/Cas9 ribonucleoprotein system.
Publications: